stocks logo

AVR

Anteris Technologies Global Corp
$
3.175
+0.17(5.657%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.220
Open
2.980
VWAP
3.11
Vol
110.06K
Mkt Cap
114.50M
Low
2.980
Amount
341.82K
EV/EBITDA(TTM)
--
Total Shares
36.06M
EV
61.97M
EV/OCF(TTM)
--
P/S(TTM)
--
Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.
Show More
4 Analyst Rating
up Image
419.69% Upside
Wall Street analysts forecast AVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVR is 16.50 USD with a low forecast of 9.00 USD and a high forecast of 22.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
up Image
419.69% Upside
Current: 3.175
sliders
Low
9.00
Averages
16.50
High
22.00
No Data

Valuation Metrics

The current forward P/E ratio for Anteris Technologies Global Corp (AVR.O) is -1.50, compared to its 5-year average forward P/E of -2.50. For a more detailed relative valuation and DCF analysis to assess Anteris Technologies Global Corp 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-2.50
Current PE
-1.50
Overvalued PE
-1.58
Undervalued PE
-3.43

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.86
Current EV/EBITDA
-0.85
Overvalued EV/EBITDA
-0.71
Undervalued EV/EBITDA
-3.02

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
48.89
Current PS
23.99
Overvalued PS
71.07
Undervalued PS
26.72

Financials

Annual
Quarterly
FY2025Q1
556.00K
Total Revenue
FY2025Q1
-21.78M
Operating Profit
FY2025Q1
-21.93M
Net Income after Tax
FY2025Q1
-0.61
EPS - Diluted
FY2025Q1
-21.74M
Free Cash Flow
FY2025Q1
62.77
Gross Profit Margin - %
FY2025Q1
N/A
FCF Margin - %
FY2025Q1
-3.94K
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
40.5K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
3.0M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

AVR News & Events

Events Timeline

2025-03-31 (ET)
2025-03-31
07:20:34
Anteris Technologies announces 100 patients treated with DurAVR THV
select
2025-03-21 (ET)
2025-03-21
07:31:47
Anteris Technologies reports one-year patient outcomes for DurAVR THV
select
Sign Up For More Events

News

9.5
05-13Newsfilter
Anteris Announces Results for the First Quarter of 2025
1.0
04-04Business Insider
Anteris Technologies management to meet with Cantor Fitzgerlad
9.0
03-31Newsfilter
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
Sign Up For More News

FAQ

arrow icon

What is Anteris Technologies Global Corp (AVR) stock price today?

The current price of AVR is 3.175 USD — it has increased 5.66 % in the last trading day.

arrow icon

What is Anteris Technologies Global Corp (AVR)'s business?

arrow icon

What is the price predicton of AVR Stock?

arrow icon

What is Anteris Technologies Global Corp (AVR)'s revenue for the last quarter?

arrow icon

What is Anteris Technologies Global Corp (AVR)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Anteris Technologies Global Corp (AVR)'s fundamentals?

arrow icon

How many employees does Anteris Technologies Global Corp (AVR). have?

arrow icon

What is Anteris Technologies Global Corp (AVR) market cap?